Navigation Links
Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride: Oral 162
Date:6/7/2009

ride (8 mg, once daily) in patients with type 2 diabetes. Patients were treated previously with diet/exercise or low doses of one oral antidiabetic drug (OAD). The trial had a 52-week randomized, double-blind period followed by the one-year extension; 59% entered the extension period of the trial and 43% of these patients completed the full two-year study period.

LEAD(TM) 3: two-year data

    Two years                Liraglutide       Liraglutide       Glimepiride
     monotherapy             1.8 mg, QD        1.2 mg, QD        8 mg, QD
                             N=154             N=149             N=137

    Diabetes duration,
     years at baseline         5.0                5.0              5.0

    Previous treatment:
    % diet/exercise             35%                38%              34%
    % OAD monotherapy           65%                62%              66%

    A1C % at baseline          8.1                8.1              8.0

    BMI, kg/m(2) at
     baseline                   33                 33               33

    Change in A1C% from
     baseline                 -1.1               -0.9             -0.6

    Change in A1C%  from
     baseline (in
     patients with <3
     years duration of
     diabetes)                -1.4               -1.1             -0.7

    % A1C <7.0%                 58                 53               37

    Change FPG (Fasting
     Plasma Glucose)
     mg/dL from baseline       -27                -24               -6

    Weight change, kg
     from baseline            -2.7               -2.1              1.1

    Minor hypoglycemic
     events/patient/year      0.23               0.21             1.76

Safety and tolerability of liraglutide

The rate of minor hypoglycemia was statistically significantly lower with both liraglutide dose groups compared to the glimepiride-t
'/>"/>

SOURCE Novo Nordisk
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients
2. Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis
3. The Lancet Publishes Two-Year Results of Abbotts Fully Bioabsorbable Drug Eluting Stent
4. Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
5. Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System
6. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
7. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
8. Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
9. Investigational Cancer Drug BSI-201 Showed Clinical Benefit in 62% of Patients with Triple-Negative Metastatic Breast Cancer and Significantly Prolonged Survival
10. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
11. Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)...  In today,s ever-changing marketplace, call centers must meet ... connected, and increasingly impatient with slow service. The need ... and tools is driving call centers to explore new ... According to research by benchmarking firm, Best Practices, LLC, ... a call center study realize the impact of social ...
(Date:7/31/2015)... 2015 More than 1,500 substance abuse prevention ... in Indianapolis Aug. 2-6 for ... Training Institute . The week-long training, held at the ... of our nation,s biggest public health challenges – youth ... is a one-of-a-kind intensive training opportunity, offering more than ...
(Date:7/31/2015)... 31, 2015 RnRMarketResearch.com adds ... research report that provides an overview of syringes ... sourced from in-house databases, secondary and primary research. ... market products pipeline spread across 124 pages, talking ... tables and 5 figures is now available at ...
Breaking Medicine Technology:Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2Community Leaders From Across The Country Head To Indianapolis For CADCA 2015 Mid-Year Training Institute Aug. 2-6 2Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5
... display at Rockefeller Plaza this month will emphasize ... almost 250,000 people per day with this important ... Industry Foundation,s National Colorectal Cancer Research Alliance (EIF,s ... Prevention,s (CDC,s) Screen for Life: National Colorectal ...
... -- CK Life Sciences Int,l., (Holdings) Inc. ("CK Life Sciences" ... and Drug Administration) has granted clearance for its subsidiary Polynoma ... proceed with Phase III clinical testing of its melanoma vaccine. ... sian Companies Cleared by FDA for Phase III Clinical Trial ...
Cached Medicine Technology:EHE International Joins Forces With Entertainment Industry Foundation's National Colorectal Cancer Research Alliance and the CDC to Encourage Screening 2CK Life Sciences Announces U.S. FDA's Clearance to Commence Phase III Clinical Testing of Melanoma Vaccine 2CK Life Sciences Announces U.S. FDA's Clearance to Commence Phase III Clinical Testing of Melanoma Vaccine 3
(Date:8/1/2015)... ... August 01, 2015 , ... BeverlyD, owner and founder of BeverlyD ... hers the very first small business donation to kick off the campaign for healing ... years. Her legacy includes a complete line of raw, organic hair care products, as ...
(Date:7/31/2015)... ... , ... Ticket Down is a reputable source of authentic tickets for the 2015 iHeart ... of every genre of music will have an act they are excited to see at ... the following artists will perform: Sam Smith, Coldplay, Kenny Chesney, The Who, Jason Derulo, ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reliable source ... in Chicago at Grant Park. The festival will end on Sunday, August 2nd. ... Chicago for the annual Lollapalooza. This unique and unbelievably popular festival attracts the ...
(Date:7/31/2015)... ... 31, 2015 , ... The 2nd annual Ride to Fight On will start ... 3, 2015. The Ride to Fight On is a cycling fundraiser that benefits the ... West Clinic and The University of Tennessee Health Science Center. A health and wellness ...
(Date:7/31/2015)... ... July 31, 2015 , ... Facebook, Twitter, Linkedin and blogs ... social media profiles to better connect with the public. The agency website at ... share insights and opinions. The Rally Insurance Group, Inc.’s pledge to provide effortless ...
Breaking Medicine News(10 mins):Health News:March4thforWellBeing Foundation Kickoff 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2
... BD (Becton,Dickinson and Company) (NYSE: BDX ), a ... at the Merrill Lynch Global,Pharmaceutical, Biotechnology and Medical Device ... The live webcast of BD,s presentation can be ... and will be available for replay,through Thursday, February 14, ...
... the Barbara Davis Center for Childhood Diabetes at the ... fight against type 1 diabetes: The Juvenile Diabetes Research ... a JDRF Autoimmunity Center at the Barbara Davis Center ... The Autoimmunity Center will receive approximately $1 million a ...
... of,Veterans Affairs (VA) today affirmed its determination to ... VA today released the results,of two investigations into ... VA,s Inspector General was contacted by Dr. Michael ... 10, 2007 and also subsequently by,Congress, to perform ...
... ... Information and Reviews, NEW YORK, Jan. 28 MWW Group ... today announced the addition of,Vitals.com to its client roster. MWW Group ... doctor evaluation,service., Vitals.com provides consumers with access -- for the ...
... of the Teamsters,walked off the job Sunday ... (ABC) Northwest distribution hub., The members ... company,s,pharmaceutical distribution segment, which supplies hospitals, healthcare,providers, ... and healthcare supplies. Over the last year, ...
... new drugs for vision-robbing disease , , MONDAY, Jan. 28 ... macular degeneration (AMD) has been developed by Cleveland Clinic ... about the development and progression of the disease and ... a leading cause of blindness in the elderly. , ...
Cached Medicine News:Health News:JDRF to establish an autoimmunity center at University of Colorado Denver 2Health News:VA Leadership Vows to Fix Problems Identified at Marion VA Medical Center 2Health News:VA Leadership Vows to Fix Problems Identified at Marion VA Medical Center 3Health News:VA Leadership Vows to Fix Problems Identified at Marion VA Medical Center 4Health News:MWW Group Selected by First-Ever Online Doctor Evaluation Service Vitals.com 2Health News:Federal Labor Law Violations Provoke Teamster Strike at AmerisourceBergen Northwest Distribution Hub 2Health News:Mouse Model of Age-Related Macular Degeneration Developed 2
Inquire...
... A revolutionary new agar plate for economically ... of this biplate with the urine specimen. If ... on the chromogenic side of the biplate will ... are E. coli, the BluEcoli™ Urine Biplate is ...
The Onar®Lp test system is an in vitro test for the qualitative diagnosis of legionella in clinical samples....
... Trinity Biotech Captia™ Legionella pneumophila ... is intended for the qualitative ... and IgM) to Legionella pneumophila ... from patients with clinical suspicion ...
Medicine Products: